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ABSTRACT: [Pt(N(R)-1,1′-Me2dma)Cl]Cl complexes with tridentate ligands (bis(1-
methyl-2-methylimidazolyl)amine, R = H; N-(methyl)bis(1-methyl-2-
methylimidazolyl)amine, R = Me) were prepared in order to investigate Pt(N(R)-
1,1′-Me2dma)G adducts (G = monodentate N9-substituted guanine or hypoxanthine
derivative). Solution NMR spectroscopy is the primary tool for studying metal
complexes of nucleosides and nucleotides because such adducts rarely crystallize.
However, [Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]NO3·5H2O (5) was crystallized,
allowing, to our knowledge, the first crystallographic molecular structure determination for a 3′-GMP platinum complex. The
structure is one of only a very few structures of a 3′-GMP complex with any metal. Complex 5 has the syn rotamer conformation,
with 3′-GMP bound by N7. All Pt(N(R)-1,1′-Me2dma)G adducts exhibit two new downfield-shifted G H8 signals, consistent
with G bound to platinum by N7 and a syn/anti rotamer mixture. Anticancer-active monofunctional platinum(II) complexes
have bulky carrier ligands that cause DNA adducts to be distorted. Hence, understanding carrier-ligand steric effects is key in
designing new platinum drugs. Ligand bulk can be correlated with the degree of impeded rotation of the G nucleobase about the
Pt−N7 bond, as assessed by the observation of rotamers. The signals of syn and anti rotamers are connected by EXSY cross-
peaks in 2D ROESY spectra of Pt(N(H)-1,1′-Me2dma)G adducts but not in spectra of Pt(N(H)dpa)G adducts (N(H)dpa =
bis(2-picolyl)amine), indicating that rotamer interchange is more facile and carrier-ligand bulk is lower in Pt(N(H)-1,1′-
Me2dma)G than in Pt(N(H)dpa)G adducts. The lower steric hindrance is a direct consequence of the greater distance of the G
nucleobase from the H4/4′ protons in the N(R)-1,1′-Me2dma carrier ligand in comparison to that from the H6/6′ protons in the
N(H)dpa carrier ligand. Although in 5 the nucleotide is 3′-GMP (not the usual 5′-GMP) and the N(H)-1,1′-Me2dma carrier
ligand is very different from those typically present in structurally characterized Pt(II) G complexes, the rocking and canting
angles in 5 adhere to long-recognized trends.
■ INTRODUCTION
High carrier-ligand bulk leads to decreases in anticancer activity
and increases in toxicity of bifunctional platinum(II) anticancer
agents,1−5 whereas for monofunctional platinum(II) agents we
believe6−9 that high carrier-ligand bulk correlates with increased
anticancer activity.9−14 Bifunctional agents, such as cisplatin,
form G*G* intrastrand cross-link lesions and cause large
distortions in DNA structure, manifested as large changes in
CD15 and NMR16,17 spectra. (G residues in DNA or oligomers
with a Pt(II) center bound to N7 are designated as G*). In
contrast, small monofunctional platinum agents, such as
[Pt(dien)Cl]Cl (dien = diethylenetriamine) and [Pt-
(NH3)3Cl]Cl, cause minimal changes in the DNA CD
14,18
and NMR16,17 spectra, indicating that monofunctional agents
with small carrier ligands are unable to distort the DNA
structure greatly upon adduct formation.6 Studies of oligomer
duplexes having one G*G* cross-link lesion (an HMG-bound
16-mer duplex studied by X-ray methods18 and a 9-mer duplex
studied by NMR methods in solution19) reveal that the DNA
distortion induced by bifunctional Pt(II) agents extends over
two base pair (bp) steps. The cross-link bp step (between the
5′-G*·C bp and the 3′-G*·C bp) and the adjacent bp step
(between the 5′-G*·C bp and the next bp in the 5′-direction
along the duplex) are both highly distorted. Both solid-state
and solution structural studies have revealed that the adjacent
bp step has a large shift and a large slide.18−20 Therefore, we
considered the possibility that this highly distorted bp step
could play an important role in anticancer activity.19,21 A
distortion very similar to that found in this adjacent bp step was
later observed in an X-ray structure of an oligomer adduct of a
bulky monofunctional platinum anticancer agent.13,22 Such
findings indicate that a monofunctional agent with bulky carrier
ligands could manifest anticancer activity by forming DNA
adducts with a highly distorted bp step similar to that found in
DNA adducts formed by nonbulky bifunctional agents such as
cisplatin. Understanding carrier-ligand steric effects is thus key
in designing new platinum drugs. Adducts formed between the
Pt agents and G ligands (G = monodentate N9-substituted
guanine or hypoxanthine derivative; Figure 1) have been
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studied by NMR methods in order to assess carrier-ligand
bulk.8,23,24
In order to gain a fundamental understanding of the steric
effects within monofunctional Pt(II) G adducts, this laboratory
has used NMR techniques to assess the properties of Pt(Ltri)G
adducts (Ltri = N,N′,N″ tridentate carrier ligand) formed by
monofunctional platinum agents with Ltri ligands based on
bis(2-picolyl)amine (N(H)dpa) or dien.6,7,25−27 The present
study focuses on the preparation of water-soluble [Pt(II)(Ltri)-
Cl]Y complexes of tridentate imidazolyl ligands and on
identifying the adducts that these complexes form in solution
with various purine derivatives. We utilize both bis(1-methyl-2-
methylimidazolyl)amine (N(H)-1,1′-Me2dma, 1) and a ligand
new to the l iterature, N -(methyl)bis(1-methyl-2-
methylimidazolyl)amine (N(Me)-1,1′-Me2dma, 2); we desig-
nate these ligands as N(R)-1,1′-Me2dma (Figure 1; R = H,
Me). The tridentate ligand N(H)-1,1′-Me2dma and its
derivatives (with a substituent on the central N: e.g.,
−CH2CH2OH) have been used to synthesize complexes of
various metals (e.g., Re, Cu, Tc, Fe) usually intended for
biomedical applications.28−35
We describe the synthesis of [Pt(N(H)-1,1′-Me2dma)Cl]Y
(3) and [Pt(N(Me)-1,1′-Me2dma)Cl]Y (4) (Y = Cl− (3a and
4a), BF4
− (3b and 4b)) and the structural characterization of
their cations by 1H NMR spectroscopy and single-crystal X-ray
diffraction. We then use 1H NMR spectroscopy to examine
Pt(N(R)-1,1′-Me2dma)G adducts formed from [Pt(N(R)-1,1′-
Me2dma)Cl]Cl complexes and compare the results to those of
other Pt(Ltri)G adducts. In the present study, the crystallization
of one product, [Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]NO3·
5H2O (5), allowed characterization by single-crystal X-ray
diffraction.
Structures of metal 3′-GMP complexes are particularly rare.
Only two molecular structures of complexes with 3′-GMP have
been described in the literature, and both are Cu(II) complexes.
One, [Cu(3′-GMP)(phen)(H2O)]2·7H2O,36 lacks M−N7
bond ing , a nd th e o th e r , ( [Cu 3 ( 3 ′ -GMP) 2 ( 3 ′ -
GMPH)2(H2O)5]·7H2O)n,
37 is a polymeric compound exhibit-
ing nucleotide metal coordination through both the N7 atoms
and the phosphate groups. Thus, to our knowledge 5 is the first
crystallographically characterized complex with any metal in
which 3′-GMP is bound through only an M−N7 bond. Other
relevant structures with one Pt−N7 bond do not contain a
nucleotide; these are [Pt(dien)(guanosine)](ClO4)2,
38 [Pt-
( d i e n ) ( i n o s i n e ) ] (NO 3 ) 2 ·H2O ,
3 9 [ P t (NH 3 ) 3 ( 9 -
methylhypoxanthine)]Cl(NO3)·1.5H2O,
40 [Pt(NH3)3(9-
ethy lhypoxanth ine)]Cl(NO3) ·H2O,




trast, there are many reported structures of complexes with
two cis Pt−N7 bonds to G ligands, quite often 5′-GMP.3,42−52
In studies of Pt(N(H)dpa)G adducts, no quality crystals for
single-crystal X-ray structures could be obtained to support the
conclusions reached by using NMR methods.6,7,25,26 The
structure of [Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]NO3·5H2O
(5) gives us deeper insights into previous findings on
Pt(N(H)dpa)G adducts, in addition to confirming and
supporting our previous analysis of solution results for
Pt(N(H)dpa)G adducts.
■ EXPERIMENTAL SECTION
Starting Materials. Sodium salts of G nucleotides (5′-guanosine
monophosphate (5′-GMP), 5′-guanosine diphosphate (5′-GDP), 5′-
guanosine triphosphate (5′-GTP), 5′-inosine monophosphate (5′-
IMP), and 3′-guanosine monophosphate (3′-GMP)), neutral purine
derivatives (inosine (Ino), 1-methylguanosine (1-MeGuo), and 9-
ethylguanine (9-EtG)), K2[PtCl4], 1-methyl-2-imidazolecarboxalde-
hyde, and methylamine hydrochloride (MeNH3Cl) were used as
received from Sigma-Aldrich. cis-Pt(DMSO)2Cl2,
53 N(H)-1,1′-
Me2dma (1),
31 and 2-(chloromethyl)-1-methylimidazole hydrochlor-
ide54 were prepared by known methods. Because the protonation state
and hence the charge of the Pt(N(R)-1,1′-Me2dma)G adducts in
which G = a nucleotide are not well-defined, we omit charges for the
adducts. However, charges are specified for structurally characterized
isolated complexes.
NMR Measurements. NMR spectra were recorded on an Avance-
III Prodigy 500 MHz Bruker spectrometer. Peak positions are relative
to TMSP-d4 in D2O or to the solvent residual peak with TMS as
reference. A presaturation pulse to suppress the water peak was
employed when necessary. All NMR data were processed with
TopSpin and MestReNova 10.0.0 software. The pH values of D2O or
65/35 D2O/DMSO-d6 solutions examined by NMR spectroscopy are
stated as measured and are not corrected for D2O. The pH
(uncorrected) of all solutions, including reaction mixtures, was
adjusted when necessary with DNO3 or NaOD (0.5 M) D2O
solutions.
Mass Spectrometric Measurements. High-resolution mass
spectra were recorded on an Agilent 6210 ESI TOF LCMS mass
spectrometer.
X-ray Data Collection and Structure Determination.
Diffraction data were collected on a Bruker Kappa Apex-II DUO
CCD diffractometer with Mo Kα radiation (λ = 0.71073 Å), equipped
with an Oxford Cryosystems Cryostream. All X-ray structures were
determined by direct methods and difference Fourier techniques and
refined by full-matrix least squares by using SHELXL201455 with H
atoms in idealized positions.
Figure 1. (top) Numbering scheme for [Pt(N(R)-1,1′-Me2dma)Cl]+
complexes containing carr ier l igands based on bis(2-
methylimidazolyl)amine (N(H)dma; R = H, Z = H). To our
knowledge, no complexes of N(H)dma with Pt are known. (bottom)
Numbering scheme for the guanine nucleobase and for 3′-GMP and
5′-GMP. Ino and 5′-IMP contain hypoxanthine, having a hydrogen
instead of the amino group at position 2 of the purine ring. The atom-
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N-(Methyl)bis(1-methyl-2-methylimidazolyl)amine (N(Me)-
1,1′-Me2dma, 2). A solution of 2-(chloromethyl)-1-methylimidazole
hydrochloride (1.00 g, 6 mmol), K2CO3 (1.7 g, 12 mmol), and
MeNH3Cl (0.16 g, 2.4 mmol) in acetonitrile (100 mL) was heated at
reflux under nitrogen for 18 h. After the mixture was cooled to room
temperature and filtered, the solvent was removed under reduced
pressure. The resulting pale yellow residue was dissolved in eluent A
(acetone/5.0 M NH4OH (80/20)) and purified by chromatography
on a silica column with eluent A. The fractions collected were spotted
and analyzed on TLC plates by using eluent A. The cleanest fractions,
as assessed by 1H NMR spectroscopy, were combined and taken to
dryness by rotary evaporation to afford a colorless oil (0.21 g, 40%
yield). 1H NMR signals (ppm) in D2O (pH 8.3): 7.09 (s, 2H, H5/5′),
6.96 (s, 2H, H4/4′), 3.68 (s, 4H, CH2), 3.56 (s, 6H, CH3), 2.25 (s,
3H, CH3).
1H NMR signals (ppm) in DMSO-d6: 7.07 (s, 2H, H5/5′),
6.76 (s, 2H, H4/4′), 3.52 (s, 4H, CH2), 3.48 (s, 6H, CH3), 2.06 (s,
3H, CH3). ESI-MS (m/z): [M + H]
+ calcd for C11H17N5, 220.1557;
found, 220.1558.
[Pt(N(H)-1,1′-Me2dma)Cl]Y (3a,b). A solution of N(H)-1,1′-
Me2dma (21 mg, 0.1 mmol) in methanol (1 mL) was added to a
methanol solution of cis-Pt(DMSO)2Cl2 (42 mg, 0.1 mmol, in 5 mL),
and the mixture was heated at 50 °C overnight. The pale yellow
[Pt(N(H)-1,1′-Me2dma)Cl]Cl (3a) solid (24 mg, 55% yield) that
formed was collected by filtration, washed with cold methanol and
then with ether, and air-dried. 1H NMR signals (ppm) in D2O (pH 4):
7.03 (d, J = 1.5 Hz, 2H), 6.85 (d, J = 1.6 Hz, 2H, H4/4′), 4.63 (d, J =
15.4 Hz, 2H, CH2), 3.67 (s, 6H, CH3); one of the methylene signals is
masked by the solvent peak. 1H NMR signals (ppm) in DMSO-d6:
8.31 (bs, 1H, NH), 7.38 (s, 2H, H5/5′), 6.93 (s, 2H, H4/4′), 4.56 (d, J
= 15.3 Hz, 2H, CH2), 4.53 (d, J = 15.0 Hz, 2H, CH2), 3.73 (s, 6H,
CH3). ESI-MS (m/z): [M + H]
+ calcd for C10H15ClN5Pt, 436.0737;
found, 436.0639. An aqueous solution of [Pt(N(H)-1,1′-Me2dma)Cl]
Cl (3a; 80 mg, 2 mL) was treated with an excess of NaBF4 (30 mg) to
yield a yellow solid. A solution of this solid in acetone (50 mg, 2 mL)
was allowed to stand at room temperature, and slow evaporation
produced pale yellow, X-ray-quality crystals of [Pt(N(H)-1,1′-
Me2dma)Cl]BF4 (3b) after 4 days.
1H NMR signals (ppm) in
DMSO-d6: 8.12 (bs, 1H, NH), 7.38 (2H, H5/5′), 6.93 (2H, H4/4′),
4.55 (d, J = 15.3 Hz, 2H, CH2), 4.53 (d, J = 15.3 Hz, 2H, CH2), 3.73
(s, 6H, CH3).
[Pt(N(Me)-1,1′-Me2dma)Cl]Y (4a,b). A solution of N(Me)-1,1′-
Me2dma (22 mg, 0.1 mmol) in methanol (1 mL) was added to a
methanol solution of cis-Pt(DMSO)2Cl2 (42 mg, 0.1 mmol, in 5 mL),
and the mixture was heated at 50 °C overnight. The pale yellow solid
(29 mg, 61% yield) that formed was collected by filtration, washed
with cold methanol and then with ether, and air-dried. X-ray-quality
crystals of [Pt(N(Me)-1,1′-Me2dma)Cl]Cl (4a) were obtained by
mixing equal volumes (1 mL) of acetonitrile solutions of cis-
Pt(DMSO)2Cl2 (10 mg, 12.5 mM) and the ligand (5 mg, 12.5 mM)
and allowing the resulting solution to stand at room temperature. Pale
yellow, needlelike crystals that separated overnight were characterized
by single-crystal X-ray crystallography. 1H NMR signals (ppm) in D2O
(pH 4, uncorrected for D2O): 7.15 (d, J = 1.5 Hz, 2H, H5/5′), 7.01 (d,
J = 1.6 Hz, 2H, H4/4′), 4.97 (d, J = 15.4 Hz, 2H, CH2), 4.64 (d, J =
15.4 Hz, 2H, CH2), 3.73 (s, 6H, CH3), 3.12 (s, 3H, CH3).
1H NMR
signals (ppm) in DMSO-d6: 7.43 (d, J = 1.6 Hz, 2H, H5/5′), 6.97 (d, J
= 1.6 Hz, 2H, H4/4′), 4.87 (d, J = 15.1 Hz, 2H, CH2), 4.72 (d, J =
15.4 Hz, 2H, CH2), 3.77 (s, 6H, CH3), 2.99 (s, 3H, CH3). An aqueous
solution of 4a (87 mg, 2 mL) was treated with an excess of NaBF4 (30
mg) to yield a yellow solid. When a solution of this solid in acetone
(50 mg, 2 mL) was allowed to stand at room temperature, slow
evaporation afforded X-ray-quality, pale yellow crystals of [Pt(N(Me)-
1,1′-Me2dma)Cl]BF4 (4b) after 2 days. 1H NMR signals (ppm) in
DMSO-d6: 7.43 (d, J = 1.7 Hz, 2H, H5/5′), 6.96 (d, J = 1.7 Hz, 2H,
H4/4′), 4.86 (d, J = 15.3 Hz, 2H, CH2), 4.71 (d, J = 15.3 Hz, 2H,
CH2), 3.77 (s, 6H, CH3), 2.99 (s, 3H, CH3).
G Adduct Formation with [Pt(N(R)-1,1′-Me2dma)Cl]Cl. A 10
mM solution of [Pt(N(R)-1,1′-Me2dma)Cl]Cl (R = H, Me) in D2O at
pH 4 (uncorrected) was treated with 2.5 molar equiv of G (G = 5′-
GMP, 5′-GTP, 3′-GMP, 5′-IMP, Ino for R = H, Me; G = 5′-GDP, 1-
MeGuo, 9-EtG for R = H). The solution was maintained at 25 °C and
at pH 4 and monitored by 1H NMR spectroscopy until the [Pt(N(R)-
1,1′-Me2dma)Cl]Cl signals completely disappeared. The signals of the
reactants are shifted by stacking interactions between free G and the
[Pt(N(R)-1,1′-Me2dma)Cl]+ cation. As the adduct formed (decreasing
the concentrations of the reactants), the resulting decrease in the
extent of stacking interactions between the reactants caused the slight
shift changes. Similar results were found in studies of Pt(N(H)dpa)G
adducts, and a more complete explanation can be found in the
published report.6
Table 1. Crystal Data and Structure Refinement Details for [Pt(N(H)-1,1′-Me2dma)Cl]BF4 (3b), [Pt(N(Me)-1,1′-
Me2dma)Cl]Cl·H2O (4a), [Pt(N(Me)-1,1′-Me2dma)Cl]BF4 (4b), and [Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]NO3·5H2O (5)
3b 4a 4b 5
formula C10H15ClN5Pt·BF4 C11H17Cl2N5Pt·OH2 C11H17ClN5Pt·BF4 C20H27N10O8PPt·NO3·5H2O
fw 522.62 503.30 536.65 913.66
cryst syst triclinic monoclinic monoclinic orthorhombic
space group P1̅ P21/c C2/c P212121
a (Å) 7.4468(4) 10.7948(6) 22.684(3) 9.0409(6)
b (Å) 12.5154(7) 11.5052(6) 12.5272(17) 16.7570(12)
c (Å) 17.0151(11) 12.2870(7) 11.2101(15) 20.8873(15)
α (deg) 110.894(2) 90 90 90
β (deg) 92.093(3) 97.773(3) 95.074(6) 90
γ (deg) 97.991(3) 90 90 90
V (Å3) 1460.77(15) 1537.19(15) 3173.1(7) 3164.4(4)
T (K) 106 90 90 90
Z 4 4 8 4
ρcalcd (Mg/m
3) 2.376 2.175 2.247 1.918
abs coeff (mm−1) 9.83 9.48 9.06 4.58
2θmax (deg) 52.8 61.0 71.8 51.4
R(F2 > 2σ(F2))a 0.035 0.030 0.030 0.037
Rw
b 0.071 0.089 0.089 0.084
resid dens (e Å−3) 1.46, −0.90 4.90, −2.56 2.39, −1.60 1.68, −0.94
no. of data/params 5955/430 4689/190 7527/212 5877/457
aR = (∑||Fο| − |Fc||)/∑|Fο|. bRw = [∑[w(Fο2 − Fc2)2]/∑[w(Fο2)2]]1/2, in which w = 1/[σ2(Fο2) + (dP)2 + (eP)] and P = (Fο2 + 2Fc2).
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In order to compare properties for the [Pt(N(H)-1,1′-Me2dma)-
Cl]+ cation and Pt(N(H)-1,1′-Me2dma)G adducts with those reported
in a D2O/DMSO-d6 (65/35) solvent mixture for the [Pt(N(H)dpa))-
Cl]+ cation and Pt(N(H)dpa)G adducts,6 the formation of selected
Pt(N(H)-1,1′-Me2dma)G adducts (G = 5′-GMP, 5′-GTP) from
[Pt(N(H)-1,1′-Me2dma)Cl]+ was studied in this solvent mixture at pH
4 (uncorrected) (Table S2 in the Supporting Information).
Crystallization of [Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]NO3·
5H2O (5). In order to obtain X-ray-quality crystals of the Pt(N(H)-
1,1′-Me2dma)(3′-GMP) adduct, 12.2 mg of 3′-GMP (2.5 molar equiv)
was added to a 20 mM solution (5.2 mg/600 μL) of [Pt(N(H)-1,1′-
Me2dma)Cl]Cl in D2O, and the pH was adjusted to 4. The solution
was allowed to stand at room temperature. Pale yellow, needlelike
crystals were collected after 2 weeks.
■ RESULTS AND DISCUSSION
Synthesis of N(R)-1,1′-Me2dma and [Pt(N(R)-1,1′-
Me2dma)Cl]Y (Y = Cl, BF4). N(H)-1,1′-Me2dma (1) was
synthesized by hydrogenation of the 1-methyl-2-imidazolecar-
boxaldehyde oxime as reported in the literature.31 Several
procedures are known30,32,56 for coupling the appropriate
amine derivative with 2 equiv of 1-methyl-2-imidazolecarbox-
aldehyde in the presence of sodium triacetoxyborohydride in
Table 2. Selected Bond Distances (Å) and Angles (deg) for [Pt(N(H)-1,1′-Me2dma)Cl]BF4 (3b), [Pt(N(Me)-1,1′-
Me2dma)Cl]Cl·H2O (4a), [Pt(N(Me)-1,1′-Me2dma)Cl]BF4 (4b), [Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]NO3·5H2O (5),
[Pt(N(H)dpa)Cl]C,la and [Pt(N(Me)dpa)Cl]Clb
3b 4a 4b 5 [Pt(N(H)dpa)Cl]Cl [Pt(N(Me)dpa)Cl]Cl
Bond Distances
Pt−N1 1.992(6) 1.992(3) 1.978(4) 2.004(8) 2.008(6) 2.006(3)
Pt−N2 2.035(13), 2.069(13) 2.042(3) 2.041(3) 2.031(9) 2.009(12) 2.017(3)
Pt−N3 1.98(2) 1.998(3) 2.002(4) 1.995(9) 2.011(5) 2.007(3)
Pt−Cl or N6 2.317(6) 2.3065(7) 2.2793(10) 2.007(8) 2.301(2) 2.3048(10)
Bond Angles
N1−Pt−N3 164.6(2) 164.27(14) 165.32(14) 164.5(4) 166.0(2) 166.0(2)
N1−Pt−Cl or N6 97.08(18) 96.21(9) 96.85(11) 96.4(4) 97.2(2) 96.62(9)
N2−Pt−Cl or N6 167.6(6), 169.9(5) 176.63(8) 176.53(9) 178.0(6) 168.7(6) 179.52(9)
N3−Pt−Cl or N6 98.27(17) 98.63(9) 97.12(12) 98.7(4) 97.8(2) 96.82(9)
N2−Pt−N1 83.1(4), 81.5(4) 82.67(12) 83.60(15) 81.6(3) 83.3(3) 83.35(12)
N2−Pt−N3 81.8(4), 83.5(4) 82.80(11) 82.73(15) 83.3(3) 83.3(3) 83.4(2)
Pt−N3−C6c 113.1(5) 111.9(2) 111.6(3) 110.6(7) 112.7(4)d 114.1(5)d
Pt−N3−C8c 139.4(5) 141.0(3) 139.5(3) 140.9(8) 127.2(5)d 128.7(5)d
C6−N3−C8c 107.1(6) 106.8(3) 108.8(4) 108.3(10) 120.1(6)d 117.0(6)d
aData from ref 63. bData from ref 64. cThe angles for the other ring are similar to the values reported here. dFor [Pt(N(H)dpa)Cl]Cl and
[Pt(N(Me)dpa)Cl]Cl the C6 and C8 numbering in the table represents the C2 and C6 atoms, respectively, in NMR discussions.
Figure 2. ORTEP plots showing the cations of [Pt(N(H)-1,1′-Me2dma)Cl]BF4 (3b, top left), [Pt(N(Me)-1,1′-Me2dma)Cl]BF4 (4b, bottom left),
and [Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]NO3·5H2O (5, right). Thermal ellipsoids are drawn with 50% probability.
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order to synthesize tridentate imidazolyl ligands having
different substituents at the central nitrogen. However, the
attempt to synthesize the N(Me)-1,1′-Me2dma (2) ligand by
this method was unsuccessful. Therefore, we employed a
coupling method known to produce tridentate pyridyl
derivatives, which involves coupling the appropriate amine
with 2-(chloromethyl)pyridine.57 Correspondingly, the cou-
pling of methylamine with 2 equiv of 2-(chloromethyl)-1-
methylimidazole under basic conditions produced N(Me)-1,1′-
Me2dma (2) in acceptable yield. Several platinum precursors,
such as cis-Pt(DMSO)2Cl2, K2[PtCl4], and Pt(1,5-
cyclooctadiene)Cl2, have been used in synthesizing platinum
complexes of pyridyl or imidazolyl ligands.58−62 The
procedures with the last two precursors use water as the
solvent. Because our complexes are highly soluble in water, we
employed cis-Pt(DMSO)2Cl2 in methanol and obtained
[Pt(N(R)-1,1′-Me2dma)Cl]Cl (3a and 4a) in 55−61% yields.
Structural Results. Crystal data and details of the structural
refinement for [Pt(N(H)-1,1′-Me2dma)Cl]BF4 (3b), [Pt-
(N(Me)-1,1′-Me2dma)Cl]Cl·H2O (4a), [Pt(N(Me)-1,1′-
Me2dma)Cl]BF4 (4b), and [Pt(N(H)-1,1′-Me2dma)(3′-
GMPH)]NO3·5H2O (5) are summarized in Table 1. Selected
bond lengths and angles are reported in Table 2, along with
data for [Pt(N(H)dpa)Cl]Cl63 and [Pt(N(Me)dpa)Cl]Cl64 for
comparison. The ORTEP plots for cations of [Pt(N(H)-1,1′-
Me2dma)Cl]BF4 (3b), [Pt(N(Me)-1,1′-Me2dma)Cl]BF4 (4b),
and [Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]NO3·5H2O (5) (Fig-
ure 2; the structure of 4a is similar to that of 4b and is not
shown here) show the numbering system used to describe the
solid-state data. Crystals of 3b contain two independent
complexes in the asymmetric unit, only one (A) of which is
shown in Figure 2 and used in the discussion. The N2 atom of
the cation [Pt(N(H)-1,1′-Me2dma)Cl]+ is disordered over two
almost equivalent positions with occupancies of 0.51:0.49
(1A:2A). Compound 4b is a nonmerohedral twin. Compound
5 was losing solvent rapidly during crystal harvesting. The
resulting crystal structure has a disordered nitrate anion and
water molecules. Hydrogen atoms of water molecules and the
phosphate moiety were not located in the difference Fourier
map. In the discussions related to the 3′-GMPH group in
complex 5, the standard numbering system for guanine
derivatives (Figure 1) is employed to allow comparisons with
known structures.
[Pt(N(H)-1,1′-Me2dma)Cl]BF4 (3b) and [Pt(N(Me)-1,1′-
Me2dma)Cl]Y (4a, Y = Cl; 4b, Y = BF4). Cations of 3b and
4a,b have a pseudo-square-planar geometry. The four
coordination sites are occupied by the N1, N2, and N3
atoms of the tridentate ligands and by a Cl atom (trans to N2).
The Pt−Cl and Pt−N bond distances and N1−Pt−N3 bite
angles in 3b and 4a,b are not significantly different from the
values reported for their [Pt(N(H)dpa)Cl]+ 63 and [Pt(N(Me)-
dpa)Cl]+ 64 analogues (Table 2). In these complexes, all of the
Pt−N bond distances lie within the ranges expected for Pt−
N(sp2) bond distances (1.99−2.08 Å)26,58,65 or Pt−N(sp3)
bond distances (2.01−2.12 Å).26,27,66,67
For the cations in 3b and 4a,b, the sp3 geometry of the
central N atom places the two methylene groups on the side of
the coordination plane opposite to the NH or N(Me) groups
(Figure 3 and Figure S1 in the Supporting Information). As a
result, the plane of the imidazolyl rings (defined by the three C
and two N atoms in the ring) is tilted with respect to the
coordination plane (defined by Pt and the four ligating atoms
N1, N3, N2, and Cl/(G)N7). The average tilt angles for rings
in [Pt(N(H)-1,1′-Me2dma)Cl]BF4 (3b), [Pt(N(H)dpa)Cl]-
Cl,63 and [Pt(N(H)6,6′-Me2dpa)Cl]Cl26 structures are 7.1, 5.4,
and 5.2°, respectively. Addition of a methyl group on the
central nitrogen appears to force the CH2 groups to be farther
below the coordination plane (Figures S1 and S2 in the
Supporting Information); consequently, the average tilt angles
approximately double to 12.4, 12.9, and 12.3° in [Pt(N(Me)-
1,1′-Me2dma)Cl]Cl (4a), [Pt(N(Me)-1,1′-Me2dma)Cl]BF4
(4b), and [Pt(N(Me)dpa)Cl]Cl,64 respectively. The tilting of
all the imidazolyl rings with respect to the coordination plane
results in the H4/4′ protons projecting toward the same side of
the coordination plane as the NH or N(Me) groups (Figure 3).
[Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]NO3·5H2O (5). The
Pt−N1, Pt−N2, and Pt−N3 (Table 2) bond distances of this
pseudo-square-planar Pt(II) complex do not differ significantly
from the values for 3b. In addition, the N1−Pt−N3 bite angle
of 5 (164.5(4)°) is comparable to the value for [Pt(N(H)-1,1′-
Me2dma)Cl]
+ in 3b (164.6(2)°, Table 2). In comparison to the
tilting observed for 3b (7.1°), the imidazolyl rings in 5 have a
greater degree of tilting. One of the imidazolyl rings is tilted by
19.1° and the other ring by 10.0°. The Pt−N7(G) bond of
2.007(8) Å in 5 falls within the typical Pt−N7(G) bond
distance ranges reported for mono adducts38−41 (1.99−2.07 Å)
and for bis adducts3,42−52 (2.02−2.08 Å). The metric
parameters and conformational features of the 3′-GMPH
ligand are normal and are described in the Supporting
Information.
The difference, Pt−N7−C5 bond angle minus the Pt−N7−
C8 bond angle, in structures of Pt(II) complexes of G (G = any
derivative of guanine) is defined as the “rocking angle”.68 The
typical range of the rocking angle, identified some years ago as
being about −2 to +11°,68 indicates that the Pt−N7−C8 angle
is normally smaller than the Pt−N7−C5 angle. Rocking angles
in more recent structures also almost always fall in this
range.40,42,44,45,48−50 Mono adducts tend to be at the lower end
of this range. Small rocking angles usually are observed when
the structure has no clear intramolecular interactions, as in
[Pt(N(H)-1,1′-Me2dma)(3′-GMPH)]+ (5), which has a
positive rocking angle of 1.4°. Rare examples of highly negative
values for the rocking angle occur only when the carrier ligand
Figure 3. Orientation of the H4/4′ protons, methylene groups, and
the imidazolyl rings in the [Pt(N(R)-1,1′-Me2dma)Cl]BF4 cations
viewed along the coordination plane: (top) 3b (R = H); (middle and
bottom) 4b (R = Me). Also shown are designations of the endo-CH
and the exo-CH protons. For clarity, the N-Me groups of the
imidazolyl rings are hidden.
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has high bulk, such as for Pt(N,N,N′,N′-tetramethylethylenedi-
amine)G2 complexes, with values of −3.2° (G = 5′-GMP)43
and −6.8° (G = 9-MeG).3
An analysis by Yao et al. of crystallographic data for cis-
[PtL2G2] type structures available at the time demonstrated a
linear correlation (R = 0.897) between the rocking angle and
the Pt−O6 non bonded distance.68 The linear correlation also
accounts for the Pt−O6 distance in 5 (3.40 Å) and in all
relevant structures published after the report by Yao et al.68 and
discussed here.40,42−45,48−50
Canting is another parameter used to compare structural
features of Pt(II) complexes of coordinated purines. If the
dihedral angle between the plane of a base and the coordination
plane is close to 90°, the base is not canted. The smaller the
dihedral angle, the greater the canting. This dihedral angle in 5
is 66.5°, indicating moderate canting. As previously re-
ported,52,69 6-oxopurine Cu(II) complexes exhibit an interest-
ing relationship between the dihedral angle and intramolecular
hydrogen-bonding interactions of the 6-oxo group with protons
in cis carrier ligands. If the proton can project out of the
coordination plane, such as a proton on a ligating sp3 N cis to
the purine, a hydrogen bond is then possible. When a hydrogen
bond is present, the dihedral angle falls in a highly canted 40−
60° range. In the absence of such an interaction, the angle is
usually greater than 65° and is in the moderately canted range.
Except for a few Pt(II) complexes exhibiting strong intra-
molecular base−base stacking between two adjacent cis
purines,42,45,46,51 all published Pt(II) 6-oxopurine complexes
also seem to follow this relationship.3,38−41,43,44,48−50,52
Accordingly, the small canting value exhibited by 5 (character-
istic of the absence of intramolecular hydrogen-bond
interactions) is consistent with the closest proton in the carrier
ligand being a partially positive CH atom lying essentially in the
coordination plane.
NMR Spectroscopy. 1H NMR spectroscopy was used to
characterize the N(Me)-1,1′-Me2dma ligand (in D2O and
DMSO-d6), the [Pt(N(R)-1,1′-Me2dma)Cl]+ complexes (in
D2O and DMSO-d6), and the Pt(N(R)-1,1′-Me2dma)G
Table 3. 1H NMR Data (ppm) for the N(R)-1,1′-Me2dma Carrier Ligands in Pt(N(R)-1,1′-Me2dma)G and in [Pt(N(R)-1,1′-
Me2dma)Cl]Cl (D2O, pH 4.0, 25 °C)
H4/4′
R Cl or G t (days)a syn anti H5/5′ 1/1′-Me N-Me
H Clb 6.85 7.03 3.67
H 5′-GMPc 6 6.53, 6.52 6.57, 6.55 7.07d 3.75
H 5′-GTPc 6 6.52, 6.51 6.56, 6.54 7.07d 3.74
H 3′-GMPc 10 6.56, 6.53 6.58, 6.57 7.09d 3.75
H 5′-IMPc 6 6.50, 6.47 6.53, 6.52 7.08d 3.76
H 5′-GDPc 4 6.52, 6.51 6.57, 6.55 7.07d 3.74
H Inoc 10 6.51, 6.49 6.54, 6.52 7.09d 3.77
H 1-MeGuoc 10 6.52, 6.51 6.55 7.09d 3.77
H 9-EtGc 10 6.52 6.54 7.10d 3.77
Me Cle 7.01 7.15 3.73 3.12
Me 5′-GMPc 10 6.58, 6.57 6.65, 6.63 7.12d 3.79 3.18
Me 5′-GTPc 10 6.58, 6.56 6.66, 6.65 7.13d 3.79 3.18
Me 3′-GMPc 10 6.61, 6.58 6.66, 6.64 7.14d 3.80 3.20
Me 5′-IMPc 10 6.54, 6.51 6.59, 6.58 7.12d 3.79 3.20
Me Inoc 10 6.55, 6.53 6.59, 6.57 7.13d 3.79 3.22
at = reaction completion time. bThe endo-H6/6′ signal is masked by the solvent peak and the exo-H6/6′ signal is 4.63 ppm (15.4 Hz). cexo- and
endo-H6/6′ signals are masked by the solvent peak. dsyn and anti signals are overlapped. eendo- and exo-H6/6′ signals are 4.97 and 4.64 ppm,
respectively.
Table 4. Selected 1H NMR Data (ppm) for the G Ligand in Pt(N(R)-1,1′-Me2dma)G Adducts (D2O, pH 4.0, 25 °C)
R G H8 free H8 syn H8 anti H1′ free H1′ syn H1′ anti Δδa syn:anti
H 5′-GMP 8.10 8.69 9.00 5.91 6.05 6.10 0.31 1.07:1
H 5′-GTP 8.19 8.74 9.05 5.92 6.05 6.09 0.31 1.01:1
H 3′-GMP 8.01 8.65 8.95 5.93 6.05 6.09 0.30 1.18:1
H 5′-IMPb 8.44 9.08 9.40 6.12 6.28 6.31 0.32 1.05:1
H 5′-GDP 8.12 8.71 9.01 5.91 6.04 6.09 0.30 1.02:1
H Inoc 8.34 9.04 9.35 6.09 6.23 6.27 0.31 1.22:1
H 1-MeGuo 7.96 8.63 8.92 5.88 6.02 6.07 0.29 1.25:1
H 9-EtGd 7.91 8.43 8.74 0.31 1.30:1
Me 5′-GMP 8.11 8.66 8.98 5.91 6.05 6.09 0.32 1.60:1
Me 5′-GTP 8.14 8.69 9.01 5.93 6.05 6.09 0.32 1.63:1
Me 3′-GMP 8.01 8.61 8.97 5.94 6.04 6.10 0.36 1.57:1
Me 5′-IMPe 8.44 9.04 9.36 6.14 6.27 6.31 0.32 1.65:1
Me Inof 8.33 8.97 9.33 6.08 6.26 6.20 0.36 1.26:1
aShift difference between the H8 signals of the syn and anti rotamers (cf. text). bH2: 8.21 (free), 8.40 (syn), and 8.34 ppm (anti). cH2: 8.21 (free),
8.40 (syn), and 8.34 ppm (anti). dCH2: 4.08 (free), 4.26 (syn), 4.21 ppm (anti). CH3: 1.41 (free), 1.48 (syn), 1.54 ppm (anti).
eH2: 8.21 (free), 8.40
(syn), and 8.32 ppm (anti). fH2: 8.21 (free), 8.40 (syn), and 8.33 ppm (anti).
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adducts (in D2O) reported here. NMR signals were assigned by
analyzing their chemical shifts, splitting pattern, integration, and
data from 2D NMR experiments. Selected 1D 1H and 13C
NMR data and assignments in D2O for [Pt(N(H)-1,1′-
Me2dma)Cl]Cl, [Pt(N(Me)-1,1′-Me2dma)Cl]Cl, and their G
adducts are collected in Tables 3−5. The atom-numbering
scheme in Figure 1 is employed in the NMR discussion. 1H
NMR results in D2O/DMSO-d6 (65/35) for Pt(N(H)-1,1′-
Me2dma)G adducts (G = 5′-GMP, 5′-GTP) appear in the
Supporting Information.
[Pt(N(R)-1,1′-Me2dma)Cl]Cl Assignments. Complexes 3
(R = H) and 4 (R = Me) each have two downfield 1H NMR
signals (Figure 4), as expected for the H4/4′ and H5/5′
aromatic protons. However, the small coupling constant of
∼1.5 Hz, combined with the effect of the nearby quadrupolar
nitrogen atoms, causes the signals to appear as singlets in some
spectra. In a ROESY spectrum (Supporting Information) in
D2O for [Pt(N(H)-1,1′-Me2dma)Cl]Cl (3a), a strong NOE
cross-peak from the 1/1′-Me signal at 3.67 ppm to the most
downfield signal (7.03 ppm) allows the signal to be assigned to
H5/5′. The other aromatic peak (6.85 ppm) can thus be
assigned to H4/4′, an assignment supported by the absence of
any NOE cross-peak from the H4/4′ signal to any other peak
except to the H5/5′ signal.
The two protons in each methylene group in the [Pt(N(R)-
1,1′-Me2dma)Cl]+ cations are not magnetically equivalent;
these are designated as endo-CH and exo-CH (Figure 3). The
two 1H NMR methylene signals are doublets. Analysis of NOE
cross-peaks led us to assign the upfield and downfield
[Pt(N(R)-1,1′-Me2dma)Cl]Cl doublets to the exo-CH and
endo-CH signals, respectively. A similar relationship was found
for [Pt(N(H)dpa)Cl]Cl.6 The 13C NMR shifts were
determined from 1D NMR spectra (Table 5). The 13C NMR
signals for the C4/4′, C5/5′, and C1/1′ carbons of [Pt(N(H)-
1,1′-Me2dma)Cl]Cl (3a) were assigned (Table 5) with the aid
of cross-peaks (in ppm) involving the H4/4′ (6.85−123.4),
H5/5′ (7.03−122.3), and 1/1′-Me (3.67−34.6) signals,
respectively, in an HSQC experiment (Supporting Informa-
tion). Cross-peaks from the endo-CH and exo-CH signals assign
the 13C NMR signal at 51.5 ppm to C6/6′. The only signal with
no HSQC cross-peak (153.92 ppm) is assigned to C2/2′. As
described in the Supporting Information, this approach for
assigning the signals of 3a was also used to assign the 1H and
13C NMR signals (Tables 3 and 5) for [Pt(N(Me)-1,1′-
Me2dma)Cl]Cl (4a).
Although the 3a and 4a structures are similar except for the
different substituents on the central N atom, the methylene
signals (in DMSO-d6) are separated by only 0.03 ppm for 3a
(an AB pattern, endo-CH at 4.56 and exo-CH at 4.53 ppm),
whereas the separation between the two doublets of 4a is 0.15
ppm (in DMSO-d6, endo-CH at 4.87 and exo-CH at 4.72 ppm).
These separations of methylene signals in [Pt(N(R)-1,1′-
Me2dma)Cl]Cl are significantly less than the values reported
for their [Pt(N(R)dpa)Cl]Cl analogues (in DMSO-d6, 0.32
6
Table 5. 1D 13C NMR Data (ppm) for [Pt(N(R)-1,1′-Me2dma)Cl]Cl (3a (R = H) and 4a (R = Me)) and for Their 5′-GMP
Adducts (D2O, pH 4.0, 25 °C)
adduct adduct
carbonsa 3a syn anti 4a syn anti
5′-GMP C8 139.96 140.03 139.96 140.04
5′-GMP C1′ 87.97 88.03
87.94 87.95
C5/5′ 122.32 122.48 122.36 122.78
122.40 122.70




C2/2′ 153.92 153.80 152.87 152.46
C6/6′ 51.02 51.50 61.95 61.94
51.44 61.90
51.39 61.88
C1/1′ 34.58 34.62 34.72 34.74
N(Me) 52.72 52.24
aFree 5′-GMP: C8, 137.48 ppm; C1′, 86.85 ppm.
Figure 4. 1H NMR spectra (25 °C, D2O, pH 4) of the complexes [Pt(N(H)-1,1′-Me2dma)Cl]Cl (3a) (top) and [Pt(N(Me)-1,1′-Me2dma)Cl]Cl
(4a) (bottom) (shifts in ppm).
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and 0.6464 ppm for R = H, Me, respectively). However, the
coupling constants for all four platinum complexes are ∼15 Hz
regardless of the carrier ligand or the substituent at the central
N.
The robustness of [Pt(N(H)-1,1′-Me2dma)Cl]Cl (3a) in
D2O (pH 7), in DMSO-d6, and under strongly acidic (0.2 M
HCl) conditions was monitored by using 1H NMR spectros-
copy. The spectra revealed no change even 10 days after
addition of HCl (Supporting Information).
Pt(N(R)-1,1′-Me2dma)G Adducts. NMR Background for
Determining Rotamer Conformation in Adducts. In
simple Pt(Ltri)G adducts, the inductive effect of the Pt(II)
center causes the H8, H2 (in hypoxanthine derivatives, cf.
Figure 1), and ribose H1′ peaks of bound G to be shifted
downfield in comparison to these signals for free G.70,71 Two G
base orientations and hence two rotamers are possible for
Pt(Ltri)G adducts having Ltri ligands that are unsymmetrical
with respect to the coordination plane but symmetrical about a
plane perpendicular to the coordination plane (Figure 5). By
convention,70 the rotamer of Pt(Ltri)G adducts having the R
group and the guanine O6 on the same side of the coordination
plane is named syn, and the rotamer having these groups on
opposite sides of this plane is named anti (Figure 5). The syn
and anti rotamers interconvert by rotation about the Pt−N7
bond.2,19,71−73 Furthermore, neither rotamer has a plane of
symmetry in an adduct formed by G derivatives having a chiral
ribose, such as 5′-GMP. Therefore, in each rotamer the
corresponding protons in the halves of the carrier ligand are not
magnetically equivalent. When NMR evdience is found that
Pt(Ltri)G rotamers exist, only two signals are found for each
type of G proton but as many as four signals can be observed
for each type of carrier-ligand proton. Such a situation, in fact,
applies to the new Pt(N(R)-1,1′-Me2dma)G adducts studied
here (Figure 6).
For separate sets of NMR signals of the syn and anti
rotamers to be observed, the carrier ligand must be bulky
enough to slow the rotation rate of the nucleobase on the NMR
time scale.70−78 For example, Pt(Me5dien)G adducts (Me5dien
= N,N,N′,N″,N‴-pentamethyldiethylenetriamine) exhibit two
sharp H8 NMR signals, one for each rotamer, indicating that
the presence of terminal dimethylamino groups provides
enough bulk to hinder nucleobase rotation about the Pt−N7
bond.70 In contrast, because of the relatively low bulk of dien,
the H8 proton of the Pt(dien)G adducts shows only one sharp
G H8 NMR peak, indicating fast rotation of the guanine base
about the Pt−N7 bond.6 Recently, the N(H)dpa ligand was
found to possess enough bulk to impede the rotation of the
guanine nucleobase in Pt(N(H)dpa)G adducts.6,7 Similarly, all
new Pt(N(R)-1,1′-Me2dma)G adducts examined in the present
study have spectra with two sharp downfield H8 NMR signals
(Figure 7 and the Supporting Information), a finding consistent
with hindered rotation of the purine base.
The main factor influencing the downfield shift of 1H NMR
signals on complex formation is the Pt(II) inductive effect, and
this effect is expected to fall off as the number of bonds
between the proton and the Pt(II) increases. However, the
inductive effect is not expected to be different for the two
rotamers. Indeed, the shift difference (Δδ) between the H8
signals of the syn and anti rotamers is only ∼0.04 ppm for the
Pt(Me5dien)(5′-GMP) adduct and Δδ = 0 for H2 in almost all
closely related 5′-IMP adducts.70 In contrast, the aromatic rings
terminating both ends of the tridentate ligand lead to large Δδ
values for H8 of ∼0.36 ppm for the Pt(N(H)dpa)G adducts.6
The syn H8 signal is upfield from the anti H8 signal. These
observations for Pt(N(H)dpa)G adducts were explained by
invoking models with a relatively uncanted guanine nucleobase
in both rotamers. In such a model, H8 is closer to the shielding
region of tilted anisotropic pyridyl groups of the carrier ligand
in the syn rotamer than in the anti rotamer, accounting for the
syn rotamer having the more upfield H8 signal.6 As we discuss
below, this explanation can be evaluated with the help of the
structure of 5 because the H8 signals of Pt(N(R)-1,1′-Me2dma)
G adducts exhibit NMR features similar to those of
Pt(N(H)dpa)G adducts.
Pt(N(H)-1,1′-Me2dma)(5′-GMP) Adduct. Spectra of the
reaction mixture of [Pt(N(H)-1,1′-Me2dma)Cl]Cl (3a) and 2.5
molar equiv of 5′-GMP in D2O (pH 4) showed new 1H NMR
signals clearly detectable about 1 h after mixing. The signals for
3a disappeared in ∼6 days (Figure 7), indicating that the
reaction was complete. In comparison to the H8 signal for free
5′-GMP at 8.10 ppm, two sharp downfield H8 singlets
characteristic of Pt(II)-bound 5′-GMP were observed. As
Figure 5. The two possible purine orientations for Pt(Ltri)G adducts
when the tridentate carrier ligand (Ltri) is unsymmetrical with respect
to the coordination plane but symmetrical about a plane perpendicular
to the coordination plane. Note that the nucleobase is represented by
an arrow with the tip at the H8 of the purine. R can be any substituent
such as H or Me.
Figure 6.Models of the two possible rotamers for Pt(Ltri)G complexes
with tridentate ligands (Ltri) unsymmetrical with respect to the
coordination plane but symmetrical about a plane perpendicular to the
coordination plane, illustrated for Ltri = N(H)-1,1′-Me2dma and G = 9-
EtG. Rotation of the ethyl group around the N9−CH2 bond creates a
time-averaged mirror plane, preserving the symmetry of the Pt(N(H)-
1,1′-Me2dma) moiety. However, if a chiral N-9 substituent is created
by replacing one methylene proton (circled), then the halves of the
Pt(N(H)-1,1′-Me2dma) moiety become magnetically inequivalent.
Inorganic Chemistry Article
DOI: 10.1021/acs.inorgchem.7b01176
Inorg. Chem. 2017, 56, 8462−8477
8469
discussed above, two H8 singlets (Figure 7) provide evidence
for impeded rotation of the guanine nucleobase in two rotamers
of the Pt(N(H)-1,1′-Me2dma)(5′-GMP) adduct; for reasons
given above, the H8 signals at 9.00 and 8.69 ppm are assigned
to the anti and syn rotamers, respectively. Furthermore, strong
EXSY cross-peaks between the syn and anti H8 signals in the
ROESY spectrum of the Pt(N(H)-1,1′-Me2dma)(5′-GMP)
adduct (Figure 8) add further strong evidence that the two
H8 signals arise from slow exchange between two rotamers. In
contrast, ROESY spectra of Pt(N(H)dpa)G adducts show no
EXSY cross-peaks,6 indicating that the exchange between
Pt(N(H)dpa)G rotamers occurs relatively more slowly than
exchange between Pt(N(H)-1,1′-Me2dma)G rotamers.
The two rotamers of the Pt(N(H)-1,1′-Me2dma)(5′-GMP)
adduct each have an H1′ doublet shifted downfield similarly
(∼0.2 ppm) by metal coordination. The NOE cross-peak
between the downfield anti H8 signal and the downfield H1′
doublet (6.10 ppm) in the ROESY spectrum (Figure 8) assigns
this H1′ doublet to the anti rotamer. The NOE cross-peak from
the syn H8 signal to the doublet at 6.05 ppm confirms its
assignment as syn H1′. Because both the H1′ and H8 protons
are associated with the five-membered ring of the guanine base,
the H1′ and H8 signals are shielded more by the tilted
imidazolyl rings in the syn rotamer than in the anti rotamer. A
similar relationship was found to be caused by the tilted pyridyl
rings in the Pt(N(H)dpa)G class of adducts.6
Figure 7. Aromatic and H1′ region of the 1H NMR spectra (25 °C, D2O, pH 4) of [Pt(N(H)-1,1′-Me2dma)Cl]+ (10 mM, bottom) and of the
reaction mixture forming Pt(N(H)-1,1′-Me2dma)(5′-GMP) recorded 15 min and 14, 24, 76, and 147 h after addition of 2.5 molar equiv of 5′-GMP
(shifts in ppm).
Figure 8. 1H−1H ROESY spectrum of Pt(N(H)-1,1′-Me2dma)(5′-GMP), showing syn H8−anti H8 EXSY cross-peaks and H8−H4/4′ and H8−H1′
NOE cross-peaks (D2O, pH 4.0, 25 °C, shifts in ppm).
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The above rotamer assignments rely on shifts of the bound
5′-GMP signals as described previously.6 The NMR features of
Pt(N(R)-1,1′-Me2dma)G adducts and the molecular structure
of 5 allow the use of NOE cross-peaks between the bound G
H8 and the carrier-ligand signals to remove any doubt about
previous assignments. From its characteristic shift and the
integration, the singlet at 3.75 ppm is unambiguously assigned
to the 1/1′-Me signal of the Pt(N(H)-1,1′-Me2dma)(5′-GMP)
adduct. The 1/1′-Me signal shows a strong cross-peak to an
apparent singlet at 7.07 ppm in the ROESY spectrum
(Supporting Information), allowing the assignment of the
7.07 ppm signal to H5/5′. This H5/5′ singlet has a strong,
broad cross-peak to four closely bunched singlets near 6.57−
6.52 ppm (Figure 8). The four singlets together integrate as
having the same intensity as the H5/5′ singlet, and thus all can
be assigned to the H4/4′ protons. These signals exhibit no
cross-peaks with the 1/1′-Me signal, confirming the H4/4′
assignment. As mentioned above, the halves of the carrier
ligand are not magnetically equivalent when the N9 substituent
is chiral (Figure 6).
In the ROESY spectra of both Pt(N(H)-1,1′-Me2dma)(5′-
GMP) (Figure 8) and Pt(N(Me)-1,1′-Me2dma)(5′-GMP)
(Supporting Information), the H8−H4/4′ NOE cross-peaks
are stronger for the anti rotamer than for the syn rotamer. To
understand this difference in NOE cross-peaks, we used the
GaussView 5.0.8 software program to construct a model of the
anti rotamer (Figure S3 in the Supporting Information) from
the molecular structure of the syn rotamer in [Pt(N(H)-1,1′-
Me2dma)(3′-GMPH)]NO3·5H2O (5). The 3′-GMP ligand of
the syn rotamer in 5 was rotated by 180° about the Pt−N7
bond and the C8−N7−Pt angle adjusted to that of the syn
rotamer (126.78°). The G H8 proton and carrier-ligand H4/4′
protons are farther apart in the syn rotamer structure (∼3.5 Å)
than in the model of the anti rotamer (∼2.8 Å). Thus, the NOE
intensities confirm the rotamer assignments using the reasoning
in previous work6 based on the effects on H8 shifts of the
anisotropy of the tilted carrier-ligand aromatic rings.
The anisotropic guanine in Pt(N(Me)dpa)G,25 Pt(N(H)-
dpa)G,6 and Pt(5,5′-Me2bipy)G275 (5,5′-Me2bipy = 5,5′-
dimethyl-2,2′-bipyridine) adducts caused large upfield shifts
(∼1.1 ppm) of the signals of the carrier-ligand protons closest
(H6/6′) to the coordinated G. Similarly, in the G adducts of 3a
and 4a, the signals of the protons closest (H4/4′) to the
coordinated G are affected the most (upfield shifts of ∼0.3−0.4
ppm in comparison to the H4/4′ signal for 3a) by adduct
formation. The nonbonded distance from the chloride atom to
the H4/4′ protons in 3b is ∼0.4 Å longer than the
corresponding distance to the H6/6′ protons in [Pt(N(H)-
dpa)Cl]Cl.63 Therefore, the coordinated guanine must be
closer to the H6/6′ protons in Pt(N(H)dpa)G adducts in
comparison to the H4/4′ protons in Pt(N(H)-1,1′-Me2dma)G
adducts (Figure 9). Hence, the guanine nucleobase will
undoubtedly cause more upfield shifting of the H6/6′ signals
than of the H4/4′ signals, as observed.
As described above, the chiral ribose in 5′-GMP makes the
halves of the carrier ligand of each Pt(N(H)-1,1′-Me2dma)(5′-
GMP) rotamer inequivalent. The effect of chirality is small.
Likewise, the difference in orientation of the nucleobase leads
to only small differences in shifts of carrier-ligand signals. As
shown in Figure 9, the distances from H4/4′ to the center of
the guanine rings in the syn rotamer are almost all identical
with the respective distances in the anti rotamer. Thus,
resolution of the four possible signals can be observed only
for signals of nuclei close to the anisotropic nucleobase of the
chiral G. The two rotamers of Pt(N(H)-1,1′-Me2dma)(5′-
GMP) exhibit four closely spaced H4/4′ signals. NOE cross-
peaks (Figure 8) from the anti H8 and syn H8 singlets to the
two most downfield and the two most upfield H4/4′ signals,
respectively, assign the H4/4′ signals (Table 3). The H5/5′
protons in Pt(N(H)-1,1′-Me2dma)(5′-GMP) are far from those
of the coordinated 5′-GMP and exhibit an apparent singlet with
a very small downfield shift change (0.04 ppm) in comparison
to the H5/5′ signal for 3a.
The 13C NMR shifts were determined from 1D NMR spectra
(Table 5). All of the carrier-ligand carbons are farther from the
anisotropic nucleobase than are the H4/4′ protons; thus, there
are usually fewer than the four possible detectable 13C NMR
signals arising from the two chiral rotamers of the Pt(N(H)-
1,1′-Me2dma)(5′-GMP) adduct. For example, only three peaks
are assignable to C4/4′ in an HSQC experiment for Pt(N(H)-
1,1′-Me2dma)(5′-GMP) (Supporting Information), in which
four clustered H4/4′ signals exhibit one strong cross-peak to
the 13C NMR peaks at 124.4, 124.3, and 124.2 ppm. Similarly,
the H5/5′ signal has a strong cross-peak to only two closely
associated peaks at 122.5 and 122.4 ppm for C5/5′. In addition,
the 1/1′-Me 1H NMR signal shows a cross-peak to the C1/1′
signal at 34.6 ppm (Table 5).
The HSQC spectrum of the Pt(N(H)-1,1′-Me2dma)(5′-
GMP) adduct (Supporting Information) is in turn useful in
locating the methylene endo-CH signals, which fall close to the
HOD solvent peak and are suppressed by presaturation of the
HOD signal. The two strong cross-peaks observed involve the
Figure 9. Overlap of stick drawings of [Pt(N(H)-1,1′-Me2dma)Cl]+
(purple) and [Pt(N(H)dpa)Cl]+ (gold) cations (by superimposing the
Pt, N1, N2, and N3 atoms). By using GaussView 5.0.8 software, 9-
methylguanine (9-MeG) adduct models were constructed from the X-
ray data by replacing the coordinated Cl atoms with a 9-MeG having a
Pt−N7 distance of 2.007 Å (the distance in 5) in the plane bisecting
the halves of the cations. These halves are almost but not exactly
equivalent (Table 2). For simplicity, the illustration replaces the purine
with a blue arrow. The syn orientation is shown. Cones qualitatively
indicate that the H4/4′ and H6/6′ atoms lie within the shielding
region of the purine base. The thin green arrows span the distances to
the center of the purine six-membered ring from the H4 and the H6
atoms in half of the carrier ligand. The averages of distances (Å) of the
H4/4′ and H6/6′ atoms to the center of the 9-MeG rings measured
using Mercury 3.7 software are as follows: for the [Pt(N(H)-1,1′-
Me2dma)(9-MeG)]
2+ models (six-membered ring, syn 4.51 and anti
4.54; five-membered ring, syn 3.63 and anti 3.63) and for the
[Pt(N(H)dpa)(9-MeG)]2+ models (six-membered ring, syn 4.13 and
anti 4.13; five-membered ring, syn 3.14 and anti 3.14). Thus, for a
given adduct and a given ring, the distances are virtually identical in
both the syn and the anti 9-MeG orientations. In all cases, distances
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C6/6′ signal (at 51 ppm, a characteristic shift for such
methylene carbons6,26,31) and the cluster of peaks at 4.60 ppm
and the suppressed signals near 4.73 ppm (Supporting
Information). We can confidently assign these 1H NMR
clusters respectively to the exo-CH and endo-CH protons
because endo-CH signals are invariably downfield, as discussed
above.
Other Pt(N(H)-1,1′-Me2dma)G Adducts. With the
progression of the reaction between [Pt(N(H)-1,1′-Me2dma)-
Cl]+ and 3′-GMP (molar ratio 1:2.5) in D2O at pH 4, the
adduct separated as pale yellow crystals. The carrier-ligand
signals in the Pt(N(H)-1,1′-Me2dma)(3′-GMP) adduct have
shifts similar to those observed for the 5′-GMP, 5′-GDP, and
5′-GTP adducts (Table 3). These observations suggest that the
location of the phosphate groups at the 3′- or 5′-position of the
sugar groups does not appear to have a major effect on the
properties of the adducts.
For the Pt(N(H)-1,1′-Me2dma)(5′-IMP) adduct, the H8
singlets are at 9.40 (anti) and 9.08 ppm (syn), and the H2
signals are at 8.40 (syn) and 8.34 (anti) ppm (Figure 10 and
Table 4). The opposite order of shifts of the H2 and H8 signals
in the anti vs the syn rotamer arises because the imidazolyl
anisotropy affects mainly the six-membered-ring signals in the
anti rotamer and mainly the five-membered-ring signals in the
syn rotamer. A similar opposite directional influence on the H2
and H8 signals by a nearby anisotropic ring was found for other
5′-IMP adducts.6,74 Because the rotamer abundance for the
Pt(N(H)-1,1′-Me2dma)(5′-IMP) adduct is very close to 1:1
(Figure 10), the relative intensities of the two H1′ signals of the
adduct were not useful for assigning the H1′ signals. The
Pt(N(Me)-1,1′-Me2dma)(5′-IMP) adduct has a syn:anti
intensity ratio of 1.65:1, and the relative intensities of the
peaks show that the syn H1′ signal is upfield and the anti H1′
signal is downfield (Supporting Information); this is the
expected shift relationship because H1′ is on the five-
membered ring. By analogy, the more upfield H1′ signal for
Pt(N(H)-1,1′-Me2dma)(5′-IMP) is assigned to the syn
rotamer. For these two Pt(N(R)-1,1′-Me2dma)(5′-IMP)
adducts, the order of shifts of the H2 signal in comparison to
the H8 and H1′ signals is opposite in the anti vs the syn
rotamer. The effect of ring anisotropy is largest on H8 shifts
and smallest on H1′ shifts. All of these shift relationships were
found also for Pt(N(H)dpa)(5′-IMP) (in a solvent mixture),6
but the shift difference between rotamers for all three types of
signals is greatest for Pt(N(H)dpa)(5′-IMP), consistent with
our conclusion below that the anisotropy of the pyridyl ring is




adducts were studied to assess the influence of the phosphate
group on the formation and properties of the adducts.
Complete formation of Pt(N(H)-1,1′-Me2dma)G adducts by
reaction of 3a with neutral nucleobases/nucleosides required
∼10 days, a longer time than for nucleotides (Table 3); the
relatively shorter reaction times observed for the 3a cation with
anionic nucleotides can be attributed to the electrostatic
attraction between the reactants.
The 1H NMR chemical shifts, Δδ values, and syn:anti ratios
for these three [Pt(N(H)-1,1′-Me2dma)G]2+ adducts are
similar to those of the adducts with nucleotides (Tables 3
and 4 and Supporting Information), indicating that phosphate
and ribose groups have at best a small influence on Δδ and on
impeding nucleobase rotation. The absence of the chiral sugar
group in the [Pt(N(H)-1,1′-Me2dma)(9-EtG)]2+ adduct results
in only one H4/4′ signal for each rotamer, giving a total of two
H4/4′ signals, not four as found with adducts in which G has a
ribose group. Furthermore, correlating the abundance of the
two sets of CH2 and CH3 signals with that of the H8 signals
establishes that the anti rotamer has the more downfield signals
for all of the protons associated with the five-membered
guanine ring (Table 4).
Comparison between Pt(N(H)dpa)G and Pt(N(H)-1,1′-
Me2dma)G Adducts. In order to compare the properties of
the new adducts with those found previously for the
Pt(N(H)dpa)G adducts,6 we conducted a few studies of
Pt(N(H)-1,1′-Me2dma)G adducts (G = 5′-GMP, 5′-GTP) in
the solvent mixture (65/35 D2O/DMSO-d6 at pH 4) used
previously for the Pt(N(H)dpa)G adducts.6 The results for
both classes of adducts, such as the syn:anti ratios, are
comparable (Supporting Information). Also, the Δδ values (in
65/35 D2O/DMSO-d6) for G = 5′-GMP, 5′-GTP are ∼0.4
ppm for Pt(N(H)dpa)G adducts and are ∼0.3 ppm for
Pt(N(H)-1,1′-Me2dma)G adducts. The nonbonded distances
between the bound Cl and the center of the aromatic rings
found in the molecular structures are shorter to the imidazolyl
rings (∼4.2 Å) of the [Pt(N(R)-1,1′-Me2dma)Cl]+ cations than
to the pyridyl rings (∼4.4 Å) of the [Pt(N(R)dpa)Cl]+
cations.63,64 The difference in these distances suggests that
H8 in adducts is farther from the center of the pyridyl rings
than from the center of the imidazolyl rings. Together with the
Δδ values for these adducts in the solvent mixture, the
difference in these distances leaves little doubt that the
anisotropy of the pyridyl ring is greater than that of the
imidazolyl ring.
Upon adduct formation, the downfield shift changes of the
H8 and H1′ NMR signals (relative to free G) are comparatively
smaller for Pt(N(H)-1,1′-Me2dma)G than for Pt(N(H)dpa)G
adducts. As an example, from data in the Supporting
Information, the H8 shift changes upon adduct formation are
0.62 and 0.91 ppm for the syn and anti rotamers of Pt(N(H)-
1,1′-Me2dma)(5′-GMP), respectively, vs 0.76 and 1.12 ppm6
for the corresponding rotamers of Pt(N(H)dpa)(5′-GMP).
Because the anisotropic effect of the pyridyl rings on H8 is
greater than that of the imidazolyl rings, the conclusion is clear
Figure 10. 1H NMR spectra (25 °C, D2O, pH 4) of the mixture of
[Pt(N(H)-1,1′-Me2dma)Cl]+ and 5′-IMP at 15 min after mixing
(bottom) and of the Pt(N(H)-1,1′-Me2dma)(5′-IMP) adduct 6 days
after mixing (top) (shifts in ppm). The spectral region was selected to
show the H8 and H2 signals.
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that the Pt(II) center exerts a stronger electron-withdrawing
effect on the nucleobase in the Pt(N(H)dpa)G than in the
Pt(N(H)-1,1′-Me2dma)G adducts. The strength of this Pt(II)
inductive effect provides a rough estimate of the relative
electron-donating ability of the bound aromatic rings. Thus, the
imidazolyl rings have a relatively higher donating ability than
the pyridyl rings, as might be expected. This difference, which
undoubtedly occurs also in the chlorido complexes, may be the
reason that complete formation of the Pt(N(H)dpa)(5′-GMP)
adduct requires less time (∼2 days) than that needed for the
Pt(N(H)-1,1′-Me2dma)(5′-GMP) adduct (≥4 days) in either
D2O (100%) or D2O/DMSO-d6 (65/35).
Pt(N(Me)-1,1′-Me2dma)G Adducts. To examine the
influence of increased bulk at the central nitrogen of the
carrier ligand, we evaluated the properties of the Pt(N(Me)-
1,1′-Me2dma)G adducts (Table 4). The Pt(N(Me)-1,1′-
Me2dma)(5′-GMP) adduct showed sharp H8 singlets for the
syn (upfield H8 signal at 8.66 ppm) and the anti (downfield H8
signal at 8.98 ppm) rotamers (Supporting Information and
Table 4). The Δδ value for the two H8 signals (0.32 ppm) is
comparable to that of Pt(N(H)-1,1′-Me2dma)(5′-GMP) (0.31
ppm). The chemical shifts for H1′ doublets of the syn and anti
rotamers of the Pt(N(Me)-1,1′-Me2dma)(5′-GMP) adduct are
similar to what is observed for the Pt(N(H)-1,1′-Me2dma)(5′-
GMP) adduct (Table 4). Similarly, the Pt(N(Me)-1,1′-
Me2dma)(5′-GTP), Pt(N(Me)-1,1′-Me2dma)(3′-GMP), Pt-
(N(Me)-1,1′-Me2dma)(5′-IMP), and Pt(N(Me)-1,1′-
Me2dma)(Ino) adducts have shifts (Tables 3 and 4 and the
Supporting Information) very similar to those of the
corresponding Pt(N(H)-1,1′-Me2dma)G adducts. However,
the EXSY cross-peaks connecting the syn and anti H8 signals
in a ROESY spectrum of the Pt(N(Me)-1,1′-Me2dma)(5′-
GMP) adduct (Supporting Information) are relatively smaller
than those of the Pt(N(H)-1,1′-Me2dma)(5′-GMP) adduct
(Figure 8), suggesting that base rotation is more facile in the
latter.
Another difference between the Pt(N(Me)-1,1′-Me2dma)G
adducts and the Pt(N(H)-1,1′-Me2dma)G adducts was the
relative abundance of the rotamers in D2O when G = 5′-GMP,
5′-GTP, 3′-GMP, 5′-IMP. The Pt(N(Me)-1,1′-Me2dma)G
adducts have a high syn:anti ratio (≥1.5:1), whereas the
Pt(N(H)-1,1′-Me2dma)G adducts have rotamers of nearly
equal abundance (Table 4). Comparison of the model of the
anti rotamer (Figure S3 in the Supporting Information) with
the molecular structure of the syn rotamer in [Pt(N(H)-1,1′-
Me2dma)(3′-GMPH)]NO3·5H2O (5) did not show any steric
interactions that would favor either rotamer, consistent with the
similar abundance of the rotamers. Finally, it is interesting to
note (1) that the imidazole ring has a greater degree of tilting in
5 than in the chlorido complexes and (2) that a methyl group
on the central nitrogen increases tilting. Thus, the greater
abundance of the syn rotamer typically found for Pt(N(Me)-
1,1′-Me2dma)G adducts than for Pt(N(H)-1,1′-Me2dma)G
adducts may arise in part because the tilting is already greater in
the starting [Pt(N(Me)-1,1′-Me2dma)Cl]Cl complex.
Relationship of the Phosphate Group to Pt(II) and N7
in GMP Complexes. The molecular structure of [Pt(N(H)-
1,1′-Me2dma)(3′-GMPH)]NO3·5H2O (5) allows us to com-
pare the proximity of the phosphate group to Pt(II) and N7 to
such distances in structurally characterized 5′-GMP complexes,
all of which are bis adducts.42−45,51 Nonbonded distances were
obtained from crystallographically determined molecular
structures by using Mercury 3.7 software. For our purposes,
we use the central P atom to gauge the distance of the
phosphate group to the other atoms. The Pt to P nonbonded
distance (9.7 Å) in the 3′-GMP complex (5) is much longer
than in the 5′-GMP complexes (5.0−6.2 Å). The NMR and
structural data for such bis 5′-GMP adducts, especially for the
ΔHT conformation (head to tail orientation of the two bases
and right-handed chirality), suggest that the phosphate group of
5′-GMP interacts electrostatically with the Pt(II) center or the
carrier ligand.43,44 Thus, the most abundant conformers often
differ between bis adducts formed by 5′-GMP and those
formed by 3′-GMP.78
The spatial position of the 3′-phosphate group in 3′-GMP
bound via N7 to a metal center separates the centers of charge.
This separation may explain why so few 3′-GMP complexes
have been crystallized. The large number of known structures
of 5′-GMP complexes of many metals may indicate that charge
neutralization resulting from the close proximity of the 5′-
phosphate group to the metal center facilitates crystallization.
Furthermore, the inability of 3′-GMP to form such
electrostatic interactions explains why formation of the
Pt(N(R)-1,1′-Me2dma)(3′-GMP) adduct requires 10 days vs
the 6 days or less needed to form the 5′-GMP, 5′-GDP, 5′-
GTP, and 5′-IMP adducts, in which a phosphate group is closer
to the Pt(II) center. The N7 to P nonbonded distance in 5 is
8.0 Å. The attraction of the negative 3′-phosphate to the
positive Pt(II) center during adduct formation positions the N7
of 3′-GMP too far from Pt(II) to facilitate N7 to Pt bond
formation. In contrast, the N7 to P nonbonded distances in 5′-
GMP adducts range from 5.1 to 6.3 Å.42−45,51 The attraction of
the negative 5′-phosphate group to the positive Pt(II) center
positions the N7 of GMP closer to Pt(II) during adduct
formation by 5′-GMP than during adduct formation by 3′-
GMP. This positioning probably accounts for the shorter times
observed for reactions of 5′-GMP than of 3′-GMP.
■ CONCLUSIONS
The presence of EXSY cross-peaks in the ROESY spectra of
Pt(N(R)-1,1′-Me2dma)(5′-GMP) adducts but not in the
ROESY spectrum of the Pt(N(H)dpa)(5′-GMP) adduct6
revealed that rotamer interchange is more facile for Pt(N(H)-
1,1′-Me2dma)G adducts than for Pt(N(H)dpa)G adducts; we
conclude that this finding establishes that the N(R)-1,1′-
Me2dma carrier-ligand steric effect is relatively lower than the
N(H)dpa carrier-ligand steric effect. We believe that this lower
steric effect is a consequence of the greater distance of the H4/
4′ protons from the G nucleobase in Pt(N(H)-1,1′-Me2dma)G
adducts in comparison to the distance of the corresponding
H6/6′ protons in Pt(N(H)dpa)G adducts.
The structural data for [Pt(N(H)-1,1′-Me2dma)(3′-
GMPH)]NO3·5H2O (5) confirm that the 3′-phosphate group
is too far from the carrier ligand or the positive Pt(II) center to
influence the properties of the complex. This finding nicely
complements a study with Pt(Me5dien)(5′/3′-GMP) adducts,
which exhibited properties independent of the 3′- or 5′-position
of the phosphate group on the ribose.70 The Me5dien carrier
ligand has considerable steric bulk projecting out of the
coordination plane, and the 5′-phosphate group cannot easily
approach the positive Pt(II) center. In analogues of Pt-
(Me5dien)(5′/3′-GMP) adducts in which protons occupied the
positions of some of the carrier-ligand N-Me groups,70,71 the
rotamer distribution greatly favored the rotamer in which the
5′-phosphate group could form a hydrogen bond to the carrier-
ligand NH proton. The solid-state structure of 5 in the present
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study thus fully supports previous less direct evidence regarding
the role of the phosphate group in influencing rotamer
abundance when the carrier ligand has NH groups in the cis
position.
Finally, the structure of [Pt(N(H)-1,1′-Me2dma)(3′-
GMPH)]NO3·5H2O (5) establishes the validity of features
deduced from NMR results for Pt(N(H)dpa)G adducts6 that
have a related tridentate ligand. In particular, the structure of 5
shows that the G nucleobase has low canting and that the
carrier-ligand aromatic rings in a G adduct are tilted, as found in
the parent chlorido complexes. In studies of Pt(N(H)dpa)G
adducts,6 the tilting of the pyridyl rings served to assign signals
to the syn or anti rotamer. The structure of 5 provides a basis
for creating models of the syn and anti rotamers. These models
indicate that the H8 to H4/4′ distance is longer in the syn than
in the anti rotamer. The relevant cross-peak intensity is larger
for the anti than for the syn signals, a finding that provides
strong support for the validity of previous rotamer assignments6




The Supporting Information is available free of charge on the
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Superimposed structures of the cations of [Pt(N(R)-1,1′-
Me2dma)Cl]BF4 (R = H, Me), models of the syn and
anti rotamers based on the molecular structure of 5,
structural features of the 3′-GMPH ligand in 5, ROESY
and 1H−13C HSQC spectra of [Pt(N(H)-1,1′-Me2dma)-
Cl]Cl, carrier-ligand assignments for [Pt(N(Me)-1,1′-
Me2dma)Cl]Cl, ROESY and
1H−13C HSQC spectra of
[Pt(N(Me)-1,1′-Me2dma)Cl]Cl, 1H NMR stack plot of
[Pt(N(H)-1,1′-Me2dma)Cl]Cl after addition of HCl, 1H








(5′-IMP) adducts, selected regions of the ROESY and
the 1H−13C HSQC spectra of Pt(N(H)-1,1′-Me2dma)-
(5′-GMP) and the ROESY spectrum of Pt(N(Me)-1,1′-
Me2dma)(5′-GMP), wide scans of the 1D 1H NMR
spectra of N(H)-1,1′-Me2dma, N(Me)-1,1′-Me2dma,
[Pt(N(H)-1,1′-Me2dma)Cl]Cl, and [Pt(N(Me)-1,1′-
Me2dma)Cl]Cl and final traces of reaction mixtures
forming Pt(N(H)-1,1′-Me2dma)(3′-GMP) and Pt-
(N(Me)-1,1′-Me2dma)(5′-GMP) adducts, and 1H
NMR data for Pt(N(H)-1,1′-Me2dma)G adducts in
D2O/DMSO-d6 (PDF)
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